- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT03609034
Knowledge, Attitude and Practice of a Group of Egyptian Dental Interns Toward Caries Risk Assessment
Assessment of Knowledge, Attitude and Practice of a Group of Egyptian Dental Interns Toward Caries Risk Assessment and Management:A Cross Sectional Study
Scientific background(Statement of the problem):
Dental caries is a disease that occurs through complex interaction of four major factors: the host, acidogenic bacteria, fermentable carbohydrates and time. There are many factors which contribute to dental caries incidence but do not seen in clinical examination. Those things are considered as dental caries risk factors, such as socioeconomic, attitudes, knowledge and behavior toward oral health. These risk factors play an important role in incidence of the disease, significantly associated with disease progression . The traditional "drill and fill "concept has served to restore function and esthetics but it has failed to prevent development of new carious lesions. In recent years; better understanding of nature of carious process has changed this operative treatment concept to non destructive risk -based caries management. Caries risk assessment is a procedure used to predict dental caries development before clinical onset of disease, through assessing risk factors contributing to progress of dental caries and let oral health care professionals to be more active in identifying and referring high risk patients for proper treatment and required prevention.
Rationale for carrying out this study : Many studies have measured dentists' knowledge toward caries risk assessment all over the world, but no studies have examined Egyptian Dentists' subjective ratings of the importance of specific caries risk factors or tested whether they use this information in treatment planning.
So the aim of this study to assess knowledge, attitude and practice toward caries risk assessment and management among group of dental interns in Egypt.
Benefits to the Dental interns:
- Challenge the knowledge of the intern dentists regarding caries risk assessment.
- Encourage the concept of minimally invasive dentistry to be applied in clinical practice.
- Accurate caries risk assessment in patients can guide clinician to give attention of their resources to high risk patients.
Benefits to the patients:
- Will benefit from proper knowledge, attitude and practice of dentists, thus proper treatment will be provided.
- Behavioral modification of patients toward oral hygiene practices.
- Reducing patient risk of developing advanced disease and may even arrest disease process.
Benefits to the Community:
-Imparting knowledge of Caries risk assessment to dentists will benefit their patients especially high-caries risk patients by giving proper preventive interventions that help to reduce the expected elevated incidence and severity of caries in the future, therefore the whole community will benefit.
Aperçu de l'étude
Statut
Les conditions
Type d'étude
Inscription (Anticipé)
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Egyptian dental interns who completed their Pediatric Dentistry round in Pediatric Dentistry and Public Health Department ,Faculty of Dentistry , Cairo University.
- Intern dentists irrespective of age and sex.
Exclusion Criteria:
- Undergraduate dental students.
- Post graduate dentists.
- Dental interns who refused to participate in the study.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
knowledge,attitude and practice of dental interns toward caries risk assessment
Délai: one year
|
structured self-administrated questionnaire
|
one year
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Anticipé)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CEBD-CU-2018-06-37
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Caries dentaires
-
The Affiliated Hospital of Xuzhou Medical UniversityRecrutementLLC | SLL | Thérapie cellulaire CAR-TChine
-
Xuzhou Medical UniversityPas encore de recrutementSurveillance non invasive des cellules CAR-T | Imagerie PET ciblant le BCMA | Biodistribution et persistance des cellules CAR-T | Préparation de Radiopharmaceutique Conforme aux BPF
-
University Health Network, TorontoRecrutement
-
Patrick C. Johnson, MDRecrutement
-
Duke UniversityNational Institutes of Health (NIH)RecrutementGreffe de cellules souches hématopoïétiques | Thérapie cellulaire CAR-TÉtats-Unis
-
The Lymphoma Academic Research OrganisationBristol-Myers Squibb; Novartis; Gilead SciencesRecrutementÉligible en hématopathologie ou traitement CAR-t CellFrance
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecrutementComplications de la thérapie CAR-TItalie
-
Shanghai International Medical CenterInconnueTumeur solide avancée | PD-1 Anticorps | Cellules CAR-TChine
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRecrutementMesures des résultats rapportés par les patients | Thérapie CAR T-CellSuisse
-
Ruijin HospitalActif, ne recrute pasALL (leucémie aiguë B-lymphoblastique) | Thérapie cellulaire CAR-TChine